Analysis of the data obtained in our study suggests that the increase in the activity of Px in the saliva of BRCA1+ patients with breast cancer indicates an intensified enzymatic antioxidant defence, protecting against oxidative damage to salivary glands and the entire oral cavity. This evidence concerns the gene BRCA1 and breast cancer.